celastrol has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; He, W; Li, X; Xu, S; Xu, W; Yang, H | 1 |
| Chan, Y; Chan, YL; Chellappan, DK; Collet, T; Dua, K; Gupta, G; Hansbro, N; Hansbro, PM; Hsu, A; Madheswaran, T; Ng, SW; Oliver, BG; Panneerselvam, J; Wark, P; Zeeshan, F | 1 |
2 review(s) available for celastrol and Metabolic Diseases
| Article | Year |
|---|---|
Celastrol in metabolic diseases: Progress and application prospects.
Topics: Animals; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Inflammation; Insulin Resistance; Lipid Metabolism; Metabolic Diseases; Obesity; Pentacyclic Triterpenes; Tripterygium | 2021 |
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities.
Topics: Animals; Arthritis, Rheumatoid; Biological Products; Drug Discovery; Humans; Inflammation; Metabolic Diseases; Pentacyclic Triterpenes; Plants, Medicinal; Tripterygium; Triterpenes | 2019 |